期刊文献+

抗结核药物对肝脏的影响及其在肝病患者中的应用 被引量:4

Effect of anti-tuberculosis drugs on liver and their application in the patients with liver diseases
下载PDF
导出
摘要 抗结核药物可导致药物性肝损害,而肝脏损害又会影响结核病患者的抗结核规范化治疗。因此,了解抗结核药物对肝脏的影响,早期发现肝脏损害并及时处理,对肝功能的恢复及抗结核治疗的成功具有重要意义。本文简要介绍抗结核药物对肝脏的影响及其在肝病患者中的应用。 Anti-tuberculosis drugs can lead to drug-induced liver injury, and liver injury may influence the treatment of tuberculosis. Therefore, the earlier diagnosis of liver injury is important for restoring liver function and completing the treatment. This review introduces the effect of anti-tuberculosis drugs on liver and their application in the patients with liver diseases.
出处 《世界临床药物》 CAS 2011年第9期526-528,共3页 World Clinical Drug
关键词 抗结核药物 药物性肝损害 肝脏疾病 临床应用 anti-tuberculosis drugs drug-induced liver injury liver diseases clinical application
  • 相关文献

参考文献9

二级参考文献47

共引文献201

同被引文献50

  • 1商明群.力克肺疾丁胺卡那治疗耐多药肺结核疗效分析[J].医药论坛杂志,2004,25(13):21-22. 被引量:4
  • 2曹莉萍,李炬,老帼慧,韦红梅,王西林,付燕.CYP1A2基因C734A多态性和奥氮平临床效应的关联研究[J].中国神经精神疾病杂志,2006,32(6):518-522. 被引量:4
  • 3PACHKORIA K, LUCENA MI, RUIZ-CABELLO F, et al. Ge- netic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI) [ J ]. Br J Pharma- col,2007, 150(6) :808-815.
  • 4XIE Y, WANG G, WANG H, et al. Cytochrome P450 dysregu- lations in thioaeetamide-indnced liver cirrhosis in rats and the counteracting effects of hepatoprotective agents [ J ]. Drug Metab Dispos, 2012,40(4) :796-802.
  • 5ISHIBE T, KIMURA A, ISHIDA Y, et al. Reduced acetamino- phen-induced liver injury in mice by genetic disruption of IL-1 re- ceptor antagonist [J]. Lab Invest, 2009, 89( 1 ) :68-79.
  • 6KURIBAYASHII S, GOTO K, NAITO S, et al. Human cyto- chrome 17450 1 A2 involvement in the formation of reactive metab- olites from a species-specific hepatotoxic pyrazolopyrimidine de- rivative, 5-n-butyl-7-( 3,4, 5-trimethoxybenzoylamino ) pyrazolo [1,5-a]pyrimidine [J]. Chem Res Toxicol, 2009, 22(2):323- 331.
  • 7VENITZ J, ZACK J, GILLIES H,et al. Clinical pharmacokinet- ics and drug-drug interactions of endothelin receptor antagonists in pulmonary arterial hypertension[ J]. J Clin Pharmacol, 2012, 52(12) :1784-1805.
  • 8BENICHOU C. Criteria of drug-induced liver disorders. Report of an intenaational consensus meeting [ J ]. J Hepatol, 1990, 1 1 (2) :272-276.
  • 9DUFOUR D R, LOTTt J A, NOLTE F S, et al. Diagnosis and monitoring of hepatic injury. I. Perfonnmace characteristics of la- boratory tests[ J]. Clin Chem, 2000, 46 (12) :2027-2049.
  • 10AZARPIRA N, NAMAZI S, HENDIJANI F, et al. Investigaion of allele and genotype frequencies of CYP2C9, CYP2CI9 and VKORC1 in Iran[ J]. Pharmacol Rep,2010,62(4) :740-746.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部